[1]
Kaware, H.H. et al. 2024. Actinomycin-D vs Methotrexate in Low-Risk Gestational Tropoblastic Neoplasia: Which is the better option?. Indonesian Journal of Obstetrics and Gynecology. 12, 4 (Oct. 2024), 263–269. DOI:https://doi.org/10.32771/inajog.v12i4.2077.